Otamixaban

Otamixaban
Identifiers
	IUPAC name methyl (2R,3R)-2-(3-carbamimidoylbenzyl)-3- {[4-(1-oxidopyridin-4-yl)benzoyl]amino}butanoate;
CAS Number	193153-04-7;
PubChem CID	5496659;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C25H26N4O4
Molar mass	446.498 g/mol

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Otamixaban (INN) is an inhibitor of Factor Xa,^[1] currently being developed by the French pharmaceutical company Sanofi-Aventis as a treatment for acute coronary syndrome.

Identifiers


IUPAC name methyl (2R,3R)-2-(3-carbamimidoylbenzyl)-3- {[4-(1-oxidopyridin-4-yl)benzoyl]amino}butanoate
CAS Number	193153-04-7
PubChem CID	5496659
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C₂₅H₂₆N₄O₄
Molar mass	446.498 g/mol